Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders

Identifieur interne : 000351 ( Istex/Corpus ); précédent : 000350; suivant : 000352

Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders

Auteurs :

Source :

RBID : ISTEX:A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C

Abstract

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of The Movement Disorder Society and The Parkinson Study Group. The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians. The symposium will consist of peer‐reviewed platform and poster presentations designed to communicate recent research advances in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other Movement Disorders to professionals in neurology and related disciplines. Practitioners, educators, and researchers are invited to attend. Abstracts of platform and poster presentations representing original material will be published in the August 2008 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify by scholarly review, oral presentation and group discussion the current research into the diagnosis, prevention and treatment of Parkinson's disease and other Movement Disorders; 2) Identify the important advances in research and clinical treatments relating to a variety of Movement Disorders; 3) Discuss new pharmacological and non‐pharmacological treatment options available for Parkinson's disease and other Movement Disorders; 4) Identify the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson's disease and other Movement Disorders; and 5) Discuss the diagnostic approaches and tools available for Parkinson's disease and other Movement Disorders.

Url:
DOI: 10.1002/mds.22237

Links to Exploration step

ISTEX:A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22237</idno>
<idno type="url">https://api.istex.fr/document/A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000351</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-08-15">2008-08-15</date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1628">1628</biblScope>
<biblScope unit="page" to="1637">1637</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C</idno>
<idno type="DOI">10.1002/mds.22237</idno>
<idno type="ArticleID">MDS22237</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of The Movement Disorder Society and The Parkinson Study Group. The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians. The symposium will consist of peer‐reviewed platform and poster presentations designed to communicate recent research advances in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other Movement Disorders to professionals in neurology and related disciplines. Practitioners, educators, and researchers are invited to attend. Abstracts of platform and poster presentations representing original material will be published in the August 2008 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify by scholarly review, oral presentation and group discussion the current research into the diagnosis, prevention and treatment of Parkinson's disease and other Movement Disorders; 2) Identify the important advances in research and clinical treatments relating to a variety of Movement Disorders; 3) Discuss new pharmacological and non‐pharmacological treatment options available for Parkinson's disease and other Movement Disorders; 4) Identify the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson's disease and other Movement Disorders; and 5) Discuss the diagnostic approaches and tools available for Parkinson's disease and other Movement Disorders.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<genre>
<json:string>Serial article</json:string>
</genre>
<host>
<volume>23</volume>
<pages>
<total>10</total>
<last>1637</last>
<first>1628</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>11</issue>
<subject>
<json:item>
<value>Abstract</value>
</json:item>
</subject>
<genre></genre>
<language>
<json:string>unknown</json:string>
</language>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<language>
<json:string>eng</json:string>
</language>
<abstract>This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of The Movement Disorder Society and The Parkinson Study Group. The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians. The symposium will consist of peer‐reviewed platform and poster presentations designed to communicate recent research advances in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other Movement Disorders to professionals in neurology and related disciplines. Practitioners, educators, and researchers are invited to attend. Abstracts of platform and poster presentations representing original material will be published in the August 2008 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify by scholarly review, oral presentation and group discussion the current research into the diagnosis, prevention and treatment of Parkinson's disease and other Movement Disorders; 2) Identify the important advances in research and clinical treatments relating to a variety of Movement Disorders; 3) Discuss new pharmacological and non‐pharmacological treatment options available for Parkinson's disease and other Movement Disorders; 4) Identify the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson's disease and other Movement Disorders; and 5) Discuss the diagnostic approaches and tools available for Parkinson's disease and other Movement Disorders.</abstract>
<qualityIndicators>
<score>7.688</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>false</refBibsNative>
<abstractCharCount>1676</abstractCharCount>
<pdfWordCount>8861</pdfWordCount>
<pdfCharCount>58558</pdfCharCount>
<pdfPageCount>10</pdfPageCount>
<abstractWordCount>224</abstractWordCount>
</qualityIndicators>
<title>Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
<publicationDate>2008</publicationDate>
<copyrightDate>2008</copyrightDate>
<doi>
<json:string>10.1002/mds.22237</json:string>
</doi>
<id>A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C/fulltext/tei">
<teiHeader type="text">
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>Wiley Subscription Services, Inc., A Wiley Company</p>
</availability>
<date>2008</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-08-15"></date>
<biblScope unit="vol">23</biblScope>
<biblScope unit="issue">11</biblScope>
<biblScope unit="page" from="1628">1628</biblScope>
<biblScope unit="page" to="1637">1637</biblScope>
</imprint>
</monogr>
<idno type="istex">A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C</idno>
<idno type="DOI">10.1002/mds.22237</idno>
<idno type="ArticleID">MDS22237</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2008</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="en">
<p>This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of The Movement Disorder Society and The Parkinson Study Group. The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians. The symposium will consist of peer‐reviewed platform and poster presentations designed to communicate recent research advances in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other Movement Disorders to professionals in neurology and related disciplines. Practitioners, educators, and researchers are invited to attend. Abstracts of platform and poster presentations representing original material will be published in the August 2008 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify by scholarly review, oral presentation and group discussion the current research into the diagnosis, prevention and treatment of Parkinson's disease and other Movement Disorders; 2) Identify the important advances in research and clinical treatments relating to a variety of Movement Disorders; 3) Discuss new pharmacological and non‐pharmacological treatment options available for Parkinson's disease and other Movement Disorders; 4) Identify the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson's disease and other Movement Disorders; and 5) Discuss the diagnostic approaches and tools available for Parkinson's disease and other Movement Disorders.</p>
</abstract>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>Article category</head>
<item>
<term>Abstract</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2008-08-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="110">
<doi origin="wiley" registered="yes">10.1002/mds.v23:11</doi>
<numberingGroup>
<numbering type="journalVolume" number="23">23</numbering>
<numbering type="journalIssue">11</numbering>
</numberingGroup>
<coverDate startDate="2008-08-15">15 August 2008</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="abstract" position="270" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.22237</doi>
<idGroup>
<id type="unit" value="MDS22237"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="10"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Abstract</title>
<title type="tocHeading1">Abstracts</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2008 Movement Disorder Society</copyright>
<eventGroup>
<event type="firstOnline" date="2008-09-12"></event>
<event type="publishedOnlineFinalForm" date="2008-09-12"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:HeaderRef result:HeaderRef" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">1628</numbering>
<numbering type="pageLast">1637</numbering>
</numberingGroup>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS22237.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="0"></count>
<count type="tableTotal" number="0"></count>
<count type="referenceTotal" number="0"></count>
<count type="wordTotal" number="9880"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
<title type="short" xml:lang="en">Abstract</title>
</titleGroup>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="US" type="organization">
<unparsedAffiliation>To be held on Sunday, 21 September 2008, in the Imperial Ballroom C & D at The Grand America Hotel, Salt Lake City, UT, USA</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<abstractGroup>
<abstract type="main" xml:lang="en">
<title type="main">Abstract</title>
<p>This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of The Movement Disorder Society and The Parkinson Study Group. The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians. The symposium will consist of peer‐reviewed platform and poster presentations designed to communicate recent research advances in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other Movement Disorders to professionals in neurology and related disciplines. Practitioners, educators, and researchers are invited to attend. Abstracts of platform and poster presentations representing original material will be published in the August 2008 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify by scholarly review, oral presentation and group discussion the current research into the diagnosis, prevention and treatment of Parkinson's disease and other Movement Disorders; 2) Identify the important advances in research and clinical treatments relating to a variety of Movement Disorders; 3) Discuss new pharmacological and non‐pharmacological treatment options available for Parkinson's disease and other Movement Disorders; 4) Identify the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson's disease and other Movement Disorders; and 5) Discuss the diagnostic approaches and tools available for Parkinson's disease and other Movement Disorders.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<!--Version 0.6 générée le 3-12-2015-->
<mods version="3.6">
<titleInfo lang="en">
<title>Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Abstract</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders</title>
</titleInfo>
<typeOfResource>text</typeOfResource>
<genre authority="originalCategForm">abstract</genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2008-08-15</dateIssued>
<copyrightDate encoding="w3cdtf">2008</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="words">9880</extent>
</physicalDescription>
<abstract lang="en">This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through joint sponsorship of The Movement Disorder Society and The Parkinson Study Group. The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians. The symposium will consist of peer‐reviewed platform and poster presentations designed to communicate recent research advances in the field of Parkinson's disease, Huntington's disease, ataxia, dystonia, myoclonus, Tourette's syndrome, tremor and other Movement Disorders to professionals in neurology and related disciplines. Practitioners, educators, and researchers are invited to attend. Abstracts of platform and poster presentations representing original material will be published in the August 2008 issue of Movement Disorders. At the conclusion of this session, participants should be able to: 1) Identify by scholarly review, oral presentation and group discussion the current research into the diagnosis, prevention and treatment of Parkinson's disease and other Movement Disorders; 2) Identify the important advances in research and clinical treatments relating to a variety of Movement Disorders; 3) Discuss new pharmacological and non‐pharmacological treatment options available for Parkinson's disease and other Movement Disorders; 4) Identify the mechanisms (genetic, environmental, pathophysiology, neurobiology) linked to Parkinson's disease and other Movement Disorders; and 5) Discuss the diagnostic approaches and tools available for Parkinson's disease and other Movement Disorders.</abstract>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<subject>
<genre>article category</genre>
<topic>Abstract</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2008</date>
<detail type="volume">
<caption>vol.</caption>
<number>23</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>11</number>
</detail>
<extent unit="pages">
<start>1628</start>
<end>1637</end>
<total>10</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C</identifier>
<identifier type="DOI">10.1002/mds.22237</identifier>
<identifier type="ArticleID">MDS22237</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Movement Disorder Society</accessCondition>
<recordInfo>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
<recordContentSource>WILEY</recordContentSource>
</recordInfo>
</mods>
</metadata>
<author></author>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000351 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 000351 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:A3170BFCEE8D19C0B79721AA31D3D3253DDAE44C
   |texte=   Twenty second annual symposium on etiology, pathogenesis, and treatment of Parkinson's disease and other movement disorders
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024